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ARTICLE
Evaluation of European coeliac disease risk variants
in a north Indian population
Sabyasachi Senapati1,6, Javier Gutierrez-Achury2,6, Ajit Sood3, Vandana Midha4, Agata Szperl2,
Jihane Romanos2, Alexandra Zhernakova2, Lude Franke2, Santos Alonso5, B K Thelma1,7,
Cisca Wijmenga*,2,7 and Gosia Trynka2,7,8
Studies in European populations have contributed to a better understanding of the genetics of complex diseases, for example,
in coeliac disease (CeD), studies of over 23000 European samples have reported association to the HLA locus and another 39
loci. However, these associations have not been evaluated in detail in other ethnicities. We sought to better understand how
disease-associated loci that have been mapped in Europeans translate to a disease risk for a population with a different ethnic
background. We therefore performed a validation of European risk loci for CeD in 497 cases and 736 controls of north Indian
origin. Using a dense-genotyping platform (Immunochip), we confirmed the strong association to the HLA region (rs2854275,
P¼8.21049). Three loci showed suggestive association (rs4948256, P¼9.3107, rs4758538, P¼8.6105 and
rs17080877, P¼2.7105). We directly replicated five previously reported European variants (Po0.05; mapping to loci
harbouring FASLG/TNFSF18, SCHIP1/IL12A, PFKFB3/PRKCQ, ZMIZ1 and ICOSLG). Using a transferability test, we further
confirmed association at PFKFB3/PRKCQ (rs2387397, P¼2.8104) and PTPRK/THEMIS (rs55743914, P¼3.4104).
The north Indian population has a higher degree of consanguinity than Europeans and we therefore explored the role of
recessively acting variants, which replicated the HLA locus (rs9271850, P¼3.71023) and suggested a role of additional
four loci. To our knowledge, this is the first replication study of CeD variants in a non-European population.
European Journal of Human Genetics (2015) 23, 530–535; doi:10.1038/ejhg.2014.137; published online 23 July 2014
INTRODUCTION
Hundreds of common variants have been established for immune-
mediated diseases, mainly from genome-wide association studies
(GWAS) in populations of European ancestry.1 A large proportion
of the European association signals replicate within non-European
populations. Yet, additional risk variants can be found using multi-
ethnic cohorts.2–5
Coeliac disease (CeD) is a common, autoimmune disorder, with a
similar prevalence among Europeans and north Indians (1–3%).6 The
largest genetic risk to CeD is conferred by the HLA haplotypes, which
account for approximately 35–40% of the risk.7 Recent progress in
understanding the genetic architecture of CeD has identified 39 non-
HLA loci.8–11 Although these analyses provided much insight into
genetic risk factors for CeD, they were largely based on European
populations, so that the risk of these associations in other non-
European populations needed to be assessed.
We explored the contribution of reported risk variants and
searched for new associated variants using a cohort of 1233 north
Indian individuals. We acknowledge the fact that about half of this
cohort contributed to the previously published Immunochip study.
However, owing to the large size of the European cohorts, it is likely
that any effect derived from the north Indian population would have
been overwhelmed by the European effects (620 north Indian
samples, which is only 2.5% of the total 24 269 samples). In this
study, we have doubled the sample size of the north Indian cohort
and analysed the transferability of known European variants to this
population. We also took advantage of the higher degree of
consanguinity in the north Indian population12 and assessed the




This study was approved by the respective institutional and university ethical
committees. Informed written consent was received from all participants.
Study populations
We used two ethnically distinct cohorts from northern India and the
Netherlands. The Indian cases (n¼ 497) and controls (n¼ 736) were recruited
from Dayanand Medical College and Hospital, Ludhiana, in Punjab (northern
India). The Indian controls included blood donors who tested negative for
CeD serology. All the Indian subjects had self-reported northern Indian
ethnicity. The Dutch cases (n¼ 1150) and controls (n¼ 1173) were recruited
from three university medical centres (Utrecht, Leiden and VUmc Amsterdam)
in the Netherlands. A small proportion of cases were recruited via the Dutch
CeD patients’ society. In both cohorts, Indian and Dutch CeD patients were
diagnosed according to standard clinical, serological and histopathological
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criteria, following the ESPGHAN criteria.13 Most of these samples have been
described elsewhere.11
DNA extraction and genotyping
Most of the DNA samples were derived from blood, or from saliva for a small
proportion of the Dutch cases and controls. Samples were hybridized on the
Immunochip platform, a custom-made chip with 196 524 markers.11
Genotyping was carried out according to Illumina’s protocol at the
genotyping facility of the University Medical Centre Groningen. The variant
calls were exported from Genome Studio with human genome GRCh36/hg18
coordinates and further converted into GRCh37/hg19 coordinates using the
UCSC liftOver tool.14
Genotype data quality control
We manually inspected cluster plots and adjusted them if required for about
150 000 markers. For about 20 000 SNPs, the assay performed poorly, and
those variants were marked as uncalled and excluded from the final analysis.
This left 178 111 high-quality SNPs that were exported from Illumina’s
Genome Studio. We required samples to have Z98% call rate. Individuals
showing a high degree of genetic relatedness (estimated kinship coefficient
40.2) or with a discordant sex were removed. Population outliers were
identified by principal component analysis (PCA) implemented in EIGEN-
SOFT 5.0.1.15,16 We excluded markers with a call rate o99% or with
significant deviation from Hardy–Weinberg equilibrium (P41 103) and
were left with 176 799 variants. A large number of Immunochip variants was of
low frequency, but our study was underpowered to assess their association in
the north Indian cohort; we therefore filtered out SNPs with a minor allele
frequency (MAF) o10%. This excluded 88 083 and 87 442 variants in the
north Indian and Dutch cohorts, respectively. We further only used the set of
variants shared across the two cohorts, resulting in 88 716 SNPs in the final
analysis. Genomic inflation for each cohort was estimated using 3016 ‘neutral’
variants present on the Immunochip array for the replication of the GWAS for
reading and writing skills and therefore unlikely to be confounded by the
immune signals.
Statistical analysis
Chip-wide analysis. For both populations, we applied additive and recessive
models using logistic regression, including the first four principal components
and gender as covariates. We used an Immunochip-wide P-value cutoff of
P¼ 3.5 106 calculated as 0.05 divided by 14 136 linkage disequilibrium
(LD)-independent SNPs (r2o0.1 computed across 100 SNPs, with a 10-SNP
sliding window) with MAF410% and based on the north Indian cohort to
determine a significant association. We used Po1 104 to report a
suggestive association. To reassess the significance of the associations detected
in this test, we also performed a minimum of 100 000 permutations to
compute empirical P-values.
Replication. We used two approaches to test for replication of the 39 non-
HLA CeD loci that have been reported in Europeans11 in the north Indian
cohort: the exact SNP replication, and the locus transferability.
 Exact SNP replication: the reported index SNPs (representing primary as
well as secondary, independent signals) were tested for association in the
north Indian cohort. We considered replication to be significant at Po0.05.
During the quality control, we removed 13 of the total of 57 independent
SNPs associated to the 39 loci because of MAFo10%. The exact SNP
replication was applied to 44 reported SNPs, representing 38 distinct loci.
 Locus transferability test: we performed a transferability test to account for
LD differences across different ethnic populations. If the causal SNP is
poorly tagged by the associated SNP reported in the discovery population
(European), the differences in LD between the north Indian and Dutch
populations could result in either a lack of replication or a different
localization of the association signal. Published LD boundaries were used to
define each of the 39 non-HLA loci.11 First, we identified all the LD-
correlated markers for each locus, measured by r2Z0.05 between the index
SNP and all the variants present in CeD loci using the Dutch controls. We
then checked the association status of these variants in the north Indian
Immunochip data set for transferability. SNP rs13132308 from the IL2/IL21
locus was not present in the north Indian data set and was replaced by its
best proxy SNP rs13151961 (r240.9 based on the Dutch controls). The
ELMO1 locus and SCHIP1/IL12A locus were excluded because the index
variants for these loci, or their proxies failed the 10% MAF filter. We
required at least one significant variant per locus. The significance threshold
was assessed in two ways. First, across all tested loci (37) we identified 142
LD-independent SNPs (pairwise r2o0.1) and used P¼ 0.05/142¼
3.52 104 as the significance threshold. Second, we used a permutation-
based test as an alternative way to account for LD structure. We performed
1000 permutations for which we randomized phenotype labels. We
identified a nominal P-value for each of the 37 loci in each of the
permutation results. We then defined the 5th percentile of the nominal
P-values as a significance threshold.
Runs of homozygosity (ROH). The north Indian population has a reported
higher degree of consanguinity,12,17–19 therefore we sought to identify if there
were significantly associated runs of homozygous variants. We first pruned
both data sets for LD using an r2Z0.8 as a threshold to avoid detecting false-
positive regions because of homozygous stretches of LD-correlated SNPs.20–22
This is particularly likely to occur for the Immunochip, as it includes regions
with a high density of markers that are often in strong LD with each other.
Then, we identified regions with ROH, which were defined as at least 50
contiguous homozygous SNPs with no interruption (without heterozygous
positions in between) and with less than 500-kb distance between neighboring
SNPs. Association of ROH regions was performed using PLINK v1.07.23
We considered a locus significant after Bonferroni correction using the total
number of ROH found per data set (8) in our analysis with a Po0.006.
We assessed the false discovery rate (FDR) by running 10 000 permutations in
which we randomly shuffled the phenotypes and reassessed the significance of
association.
Data availability
Genotype data for the north Indian cohort are available through the European
Genome-phenome Archive (https://www.ebi.ac.uk/ega/) under the accession
number EGAS00001000849. The summary statistics can be obtained by
contacting the authors directly.
RESULTS
We obtained high-quality genotype data for 88 716 common SNPs
that were shared between the north Indian and Dutch cohorts. PCA
revealed different clustering patterns between the two cohorts,
consistent with their different ethnicities. Furthermore, the case–
control samples were homogeneous within each of the data sets
(Supplementary Figure 1). We used the first four principal compo-
nents to control for possible population substructure and did not
observe significant genomic inflation in any of the data sets
(lIndia¼ 1.036, lNetherlands¼ 1.039).
The strongest association in the north Indian cohort was present at
the HLA locus. Comparable to the Dutch sample, the SNP rs2854275
was the top signal (pIndia¼ 8.17 1049, ORIndia¼ 6.97 (5.38–9.04));
pDutch¼ 4.413 10121, ORDutch¼ 10.08 (8.3–12.23)). This replicated
the known, very strong effect of HLA in CeD. No other locus reached
genome-wide significance (Figure 1 and Table 3). The rs4948256 at
10q21.2 in the ANK3 gene reached our Immunochip-wide
significance threshold (P¼ 9.28 107, ppermuted¼ 1 106). The
rs4758538 at 11p15.4 in the OSBPL5 gene (P¼ 8.57 105,
ppermuted¼ 7.93 105) and rs17080877 at 18q22.2 near the DOK6
gene (P¼ 2.68 105, ppermuted¼ 1.7 105) both were suggestively
associated. None of these associations could be replicated in the
Dutch cohort.
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Replication of European associations in the north Indian cohort
using exact and transferability tests
The exact association in the north Indian cohort was observed at five
previously reported loci, corresponding to FASLG/TNFRSF18
(rs12142280, P¼ 0.002, OR¼ 0.69 (0.54–0.87)), ICOSLG
(rs58911644, P¼ 0.004, OR¼ 0.68 (0.51–0.88)), PFKFB3/PRKCQ
(rs2387397, P¼ 0.02, OR¼ 0.77 (0.61–0.96)), SCHIP1/IL12A
(rs2561288, P¼ 0.03, OR¼ 1.2 (1.01–1.44)) and ZMIZ1 (rs1250552,
P¼ 0.03, OR¼ 1.2 (1.01–1.44)) (Table 1). At all these variants, the
directions of association were the same as those previously reported
(Supplementary Table 1). Three of these five loci, FASLG/TNFRSF18,
ZMIZ1 and ICOSLG, previously reached Po0.05 in the north Indian
samples used in the initial study by Trynka et al11 (Supplementary
Table 1).
Using the transferability analysis of 39 loci, we observed two
associations, which passed two independent significance thresholds
(Table 2). One was at the PFKFB3/PRKCQ locus represented by the
SNP rs744254 (P¼ 2.8 104, OR¼ 0.70 (0.57–0.84)); the other was
at the PTPRK/THEMIS locus, rs4142030 (P¼ 3.4 104, OR¼ 1.39
(1.16–1.66)) (Supplementary Table 2).
Recessive analysis in the north Indian population
The ROH analysis identified 16 genomic regions with 450
consecutive homozygous SNPs each; two regions showed suggestive
association with CeD in the north Indian cohort. They were located
on chromosomes 2q11.2 (P¼ 4.1 103, FDR¼ 0.11) and 6p21.33
(P¼ 1.4 104, FDR¼ 0.0001) (Supplementary Table 3). None of
those regions replicated in the Dutch cohort.
Complementary to the ROH analysis, we also applied a recessive
model to test for association across all 88 716 SNPs. Apart from the
SNP rs9271850 (P¼ 3.67 1023, OR¼ 0.12 (0.08–0.18)) located in
the HLA locus, we observed four variants (MAF40.25) at four loci
that reached the threshold of suggestive association (Po1 104;
Figure 1 and Table 3). The rs744253 at 10p15.1 (P¼ 9.27 105,
OR¼ 0.3859; ppermuted¼ 6.7 105) corresponds to PFKFB3/
PRKCQ locus that was replicated in the direct association and
Figure 1 Additive and recessive association results in the north Indian population. Manhattan plot of association under (a) an additive and (b) a recessive
model for the north Indian (blue dots) and Dutch populations (black dots). The Immunochip-wide significance cutoff (P¼3.5106) is depicted as a
green dotted line and suggestive significance threshold as a red dotted line (P¼1.0104). We excluded the HLA region.
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transferability tests described above. The remaining three loci were
new suggestive associations, with the strongest observed at the
intergenic SNP rs963872 (P¼ 1.2 105, OR¼ 2.01 (1.47–2.75);
ppermuted¼ 1.2 105) at 5p15.33, near IRX2 gene, followed by
rs10994257 (P¼ 1.8 105, OR¼ 2.5 (1.67–3.99); ppermuted¼ 5 106)
at 10q21.2 mapping to the ANK3 gene and rs6010998 (P¼ 6.17 105,
OR¼ 2.8 (1.67–4.66); ppermuted¼ 2.5 105) at 20q13.33 in the
RTEL1 gene.
DISCUSSION
Recent trans-ethnic studies have indicated that a large proportion of
common disease- or trait-associated variants established in popula-
tions of European descent also contribute to the risk in other ethnic
groups.4,24,25 Yet this observation cannot be generalized because only
a few of the GWAS were conducted in non-European populations.26
Novel loci have been reported in these limited studies.27,28 Thus, more
multi-ethnic studies may help identify not only shared disease
determinants, but also additional risk variants, which may provide
leads toward a better understanding of the disease biology.29
To our knowledge, there have been very few genetic association
studies for CeD performed in non-European populations, and those
that have been published have focused only on the HLA effects based
on very small sample size.30–36 In this study, we attempted to validate
known genetic determinants of CeD and identify potentially novel
loci in the north Indian population. We used the Immunochip
genotyping platform for this study because it offers the highest
coverage of regions associated to immune-related disorders, including
those conferring risk to CeD.
Given our modest sample size and the limited power of our study, it
is likely that the real replication rate of the European associations in
the north Indian population is much greater than we can report here.
In this context, it should be mentioned that although half of the
samples of the north Indian cohort were previously analysed in the
study by Trynka et al,11 the study focused strongly on the effects in
samples of European ancestry (97% of the 24 269 samples were of
European descent). In this study, we wanted to focus specifically on
the role of the European variants in the north Indian population and
to explore potential new associations that could have been diluted in
the previous study because of the dominance of the European cohorts.
Table 1 Five loci that were significantly (Po0.05) replicated in the north Indian cohort in the exact SNP test
Locus Chr SNP ID Genomic position (bp)a Allele Frequency cases Frequency controls P-value OR (95% CI)
FASLG/ TNFSF18 1 rs12142280 172 864 652 A 0.15 0.19 2.38E–03 0.69 (0.54–0.87)
SCHIP1/IL12A 3 rs2561288 159 674 928 T 0.48 0.48 0.038 1.2 (1.01–1.44)
PFKFB3/PRKCQ 10 rs2387397 6 390 192 G 0.19 0.23 0.020 0.77 (0.62–0.96)
ZMIZ1 10 rs1250552 81058 027 A 0.45 0.41 0.039 0.83 (0.70–0.99)
ICOSLG 21 rs58911644 45629 121 T 0.11 0.15 4.23E–03 0.68 (0.52–0.88)
aCoordinates are provided in human genome reference hg19.










PTPRK/THEMIS 6 rs55743914 rs4142030 128 154 686 G 0.40 3.39E–04 1.39 (1.16–?1.67) 6.0E–04 1.32E–03
PFKFB3/PRKCQ 10 rs2387397 rs744254 6 392 848 G 0.36 2.80E–04 0.70 (0.58–0.84) 4.0E–04 8.25E–04
aCoordinates are provided in human genome reference hg19.
Table 3 Association results for Immunochip-wide additive and recessive models in the north Indian population compared with the same








Controls Model P-value OR P-value OR
HLA 6 rs2854275 32 736 406 T 0.50 0.15 Additive 6.97 8.17E–49 4.41E–121 10.08
ANK3 10 rs4948256 61 956 912 A 0.30 0.22 Additive 1.66 9.28E–07 0.01395 1.202
OSBPL5 11 rs4758538 3 162 394 T 0.23 0.28 Additive 0.65 8.57E–05 0.8804 0.9889
Intergenic (close to DOK6) 18 rs17080877 67 016 479 C 0.14 0.10 Additive 1.82 2.68E–05 0.4274 0.9276
HLA 6 rs9271850 3 2595 060 A 0.33 0.60 Recessive 0.12 3.68E–23 2.18E–47 0.1374
Intergenic (close to IRX2) 5 rs963872 2 857 542 C 0.48 0.42 Recessive 2.01 1.20E–05 0.4407 1.168
PFKFB3/PRKCQ 10 rs744253 6 393 009 A 0.29 0.34 Recessive 0.39 9.27E–05 0.7184 0.9385
ANK3 10 rs10994257 61 982 048 T 0.34 0.26 Recessive 2.59 1.80E–05 0.7731 1.041
RTEL1/TNFRSF6B 20 rs6010998 62 294 402 A 0.28 0.25 Recessive 2.81 6.17E–05 0.1459 1.279
We used an Immunochip-wide P-value cutoff of P¼3.5106 to report a significant association and P¼1104 for suggestive association.
aCoordinates are provided in human genome reference hg19.
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Our study suffers from a small sample size and lack of replication, for
these reasons we acknowledge that the results presented here need to
be validated further in future replication studies.
We successfully replicated HLA and five of the 38 tested European
SNPs (13%); these included the loci harbouring the FASLG/TNFSF18,
SCHIP1/IL12A, PFKFB/PRKCQ, ZMIZ1 and ICOSLG genes. The
transferability test further confirmed association to the PFKFB/
PRKCQ locus and identified an additional association to a variant
at the PTPRK/THEMIS locus with suggestive evidence of association.
The top association at this locus, rs4142030, has a very low correlation
with the European index variants (r2¼ 0.083, D0 ¼ 0.53) and is
located in intron 2 of THEMIS, in contrast to the European-
associated SNP, which is located in intron 30 of PTPRK. Given that
our study was underpowered, we acknowledge that these suggestive
associations must be further replicated in north Indian populations.
However, it is tempting to speculate that this localization of the
association signal could result from the independent effects of each of
the genes in the different ethnicities. Both genes are of functional
relevance to CeD aetiology and a recent study showed that the mRNA
levels between these two genes have higher expression levels in CeD
patients but not in controls.37
The analysis of the recessive effects implicated multiple genomic
regions at a suggestive significance. With the run of homozygosity
test, we found a suggestive association to a region at 2q11.2 that spans
1.14 Mb and includes the LYG1, TXNDC9, EIF5B, REV1, AFF3 and
LONRF2 genes. This region has been associated with multiple
immune-related phenotypes, including type 1 diabetes (T1D) and
rheumatoid arthritis (RA).38–40 The second region maps to the HLA
locus at 6p21 and contains the MICA gene, which is also a locus with
a pleiotropic effect in phenotypes such as Behcet’s disease, RA or
HCV-induced hepatocellular carcinoma.41–47 The Immunochip-wide
analysis under a recessive model suggested four loci that have also
been linked to other phenotypes, for example, ANK3, which has been
associated with psychiatric disorders,48,49 and with other loci that
include PFKFB3/PRKCQ and RTEL1/TNFRSF6B reported to be
associated with immune-related diseases such as T1D, RA and
irritable bowel disease.39,50–63 Apart from HLA, the ANK3 locus was
the only one that passed Immunochip-wide significance threshold
when we considered the additive model. None of these loci were
replicated in the Dutch cohort, which could reflect a population-
specific effect, but they require further replication in the north Indian
population to robustly establish their association with a genome-wide
significance. Although the genes mapping to the associated loci that
we report here appear to be relevant candidates for CeD pathogenesis,
our study was biased toward identifying biologically relevant genes
because the Immunochip was designed to specifically target regions
previously reported as associated to immune-related diseases.
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